Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to determine the plasma levels of CRD007 in patients with abdominal aortic aneurysms after the administration of single doses of tablets containing 10, 25 and 40 mg CRD007.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01723618
Study type Interventional
Source RSPR Pharma AB
Contact
Status Completed
Phase Phase 1
Start date November 2012
Completion date November 2012